StockData
Nexalin Technology, Inc. logo

Nexalin Technology, Inc. (NXL) stock

NXLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$1.44−0.06 (-4.00%)

Close on Nov 18, 2026Market cap $31.73MP/E –Yield –

Nexalin Technology operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Nexalin Technology's operating cash flow for the twelve months ending Jun 30, 2026 was -$6.13M. For fiscal 2025 it was -$4.96M. The highest annual figure on record is -$1.08M in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$4.96M–
FY2024Dec 31, 2024-$3.94M–
FY2023Dec 31, 2023-$3.84M–
FY2022Dec 31, 2022-$2.22M–
FY2021Dec 31, 2021-$1.08M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.80M–
Q1 FY2026Mar 31, 2026-$1.71M–
Q4 FY2025Dec 31, 2025-$1.15M–
Q3 FY2025Sep 30, 2025-$1.47M–
Q2 FY2025Jun 30, 2025-$917.17K–
Q1 FY2025Mar 31, 2025-$1.43M–
Q4 FY2024Dec 31, 2024-$1.13M–
Q3 FY2024Sep 30, 2024-$800.21K–
Q2 FY2024Jun 30, 2024-$1.25M–
Q1 FY2024Mar 31, 2024-$763.29K–
Q2 FY2023Jun 30, 2023-$815.61K–
Q1 FY2023Mar 31, 2023-$1.31M–
Q4 FY2022Dec 31, 2022-$906.46K–
Q3 FY2022Sep 30, 2022-$943.70K–
Q2 FY2022Jun 30, 2022-$162.27K–
Q1 FY2022Mar 31, 2022-$203.27K–
Q4 FY2021Dec 31, 2021-$409.09K–

More Nexalin Technology figures

See a number that looks wrong?